Clinical Trial Update: A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA） [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 clinical trial of NCR100 Injection for knee osteoarthritis, sponsored by Nuwacell Biotechnologies Co., Ltd. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• NCR100 Injection (NCR100)

Snippet

Sponsor: Nuwacell Biotechnologies Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING